top of page
rectangle_blue.jpg

MENU

The invitation-only Vanguard Forums bring together Life Sciences CEOs in a uniquely enriching dialogue with each other and a faculty of peers, board members, and other experts. Together, the participants share what works–and what does not–along with perspectives on leadership opportunities and challenges across their sectors.​

The forums develop critical top leadership insights, skills, and capabilities through pragmatic learnings not found via conventional conferences or business school offerings. The forum leadership experience is just one aspect of a Vanguard Network membership. Monthly events for members allow CEOs to share experiences and network with peers in a private, by-invitation only space.

Where Life Sciences CEO Members Engage in Building High-Performance Leadership

VANGUARD FORUMS FOR LIFE SCIENCES CEOs

OVERVIEW

    • Building high-performance teams and cultures

    • Looking Around Corners

    • Getting your Pipeline in front of Big Pharma

    • Leading in the accelerating and converging environment: building new competencies and capabilities

    • Managing Board relations in an era of shareholder activism

    • Learning and adopting best practices from other companies and industries

    • Workshop: Creating your company narrative

    • Cultivating a culture of digital innovation: New strategies on leadership and talent to shape the future of your industry​

  • Forum participants are members of the Vanguard Network. Other C-suite executives and Board Members from across the global business ecosystem may be invited to join as faculty to help enrich the conversations.​

  • Participants are accepted into the Vanguard Forums in two ways. The forums extend direct invitations to existing members of the Vanguard Life Sciences CEO network and to other high-talent individuals identified by the advisory boards, faculty members and industry leaders.

  • A select number of industry-leading organizations are invited to collaborate on Vanguard Forums and other activities. 

    Partners participate in our Forums as peers and experts in their domains. This builds and reinforces top tier relationships for the long term and sets our collaborators apart as a trusted partner, moving the needle from Vendor to Peer.

    For partnership opportunities, please explore our partner deck
     

    • Murray Aitken, IQVIA Institute for Human Data Science

    • Tom Appio, Bausch Health Companies Inc.

    • Beth Boland, Foley & Lardner

    • Orlan Boston, EY

    • Judy Gawlik Brown, Belden

    • Carrie Cox, Organon

    • Kate Cronin, Moderna

    • Christian Desrosiers, Visceral AI

    • Eric Dube, Travere Therapeutics

    • Cameron Durrant, Taran Therapeutics, Inc.

    • Jay Galeota, Kallyope

    • Julie Gerberding, Foundation for the National Institutes of Health

    • Corinne Le Goff, Viatris 

    • Fred Hassan, Warburg Pincus LLC

    • Paul Hastings, Nkarta Therapeutics

    • Ray Jordan, Putnam Insights LLC

    • Dale Keshishian, HealthWorks Academies

    • Shabbi Khan, Foley & Lardner

    • David King, KingMan LLC

    • Kathy Ku, Wilson Sonsini Goodrich & Rosati

    • Jeremy Levin, Ovid Therapeutics

    • Nancy Lurker, EyePoint Pharmaceuticals

    • Aaron Mertz, The Aspen Institute

    • Matthew Meyer, Wilson Sonsini Goodrich & Rosati

    • Viq Pervaaz, The Vanguard Network

    • David Pyott, London Business School

    • Cal Roberts, Lighthouse Guild

    • Craig Tooman, Silence Therapeutics

bottom of page